NEWCASTLE UPON TYNE, UK, 22 December 2020. QuantuMDx today confirms its diagnostic assay for SARS-CoV-2 remains suitable for detecting all available virus strains, following the identification of a new variant
QuantuMDx is dedicated to making transformative, quality diagnostic technologies accessible to everyone, so that diseases can be detected and treated earlier, and transmission eradicated.
